Paperspregnancy3074407

Prior Preterm or Small-for-Gestational-Age Birth Related to Maternal Metabolic Syndrome

Obstetrics and gynecology · 01-2-2011 · 3074407 on PMC →
Entities in this paper
Targeted metabolic screening Targeted glucose and metabolic screening preterm severity-stratified metabolic screening Metabolic Syndrome Cystic fibrosis transmembrane conductance regulator-related metabolic syndrome Metabolic Syndrome Glucose Metabolism Disorders Laminopathy with severe metabolic syndrome and myopathy

Extracted findings (3)

Women with prior preterm birth had elevated risk of metabolic syndrome 8 years postpartum compared with women with term births (23% preterm vs 17% control; adjusted OR 1.76, 95% CI 1.06-2.80), driven

Effect: decline; OR 1.76; CI: 95% CI 1.06, 2.80

Size: OR 1.76 CI: 95% CI 1.06, 2.80

Women with prior SGA births had elevated glucose metabolism despite being leaner than controls, with SGA <5th percentile having 3.30 times the risk of elevated fasting glucose (>110 mg/dL) compared wi

Effect: decline; OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percentile; CI: 95% CI 1.12, 7.85

Size: OR 3.30 for elevated glucose (>110 mg/dL) in SGA <5th percen CI: 95% CI 1.12, 7.85

Late preterm (34-<37 weeks) women met Joint Statement MetS criteria (OR 1.82, 95% CI 1.05-2.86), while early preterm (<34 weeks) women had 2-3 times higher risk of hypertriglyceridemia and low HDL but

Effect: mixed; OR 1.82 (late preterm MetS by Joint Statement); CI: 95% CI 1.05, 2.86

Size: OR 1.82 (late preterm MetS by Joint Statement) CI: 95% CI 1.05, 2.86